Skip to main content

Jones James's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Aug 13, 2021

Accession no.
0001209191-21-051438
Filed
Aug 13, 2021
Trade date
Jul 8-30, 2021
Filing delay
36 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 17 non-derivative transactions. Open-market purchases total $2.37K. It was filed 36 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones JamesCIK 0001490829Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 8, 2021Common StockPPurchaseAcquired+42$3.18+$133.5614,742Direct
Jul 9, 2021Common StockPPurchaseAcquired+42$3.13+$131.4614,784Direct
Jul 12, 2021Common StockPPurchaseAcquired+42$3.33+$139.8614,826Direct
Jul 13, 2021Common StockPPurchaseAcquired+42$3.48+$146.1614,868Direct
Jul 14, 2021Common StockPPurchaseAcquired+42$3.33+$139.8614,910Direct
Jul 15, 2021Common StockPPurchaseAcquired+42$3.27+$137.3414,952Direct
Jul 16, 2021Common StockPPurchaseAcquired+42$3.28+$137.7614,994Direct
Jul 19, 2021Common StockPPurchaseAcquired+42$3.23+$135.6615,036Direct
Jul 20, 2021Common StockPPurchaseAcquired+42$3.24+$136.0815,078Direct
Jul 21, 2021Common StockPPurchaseAcquired+42$3.26+$136.9215,120Direct
Jul 22, 2021Common StockPPurchaseAcquired+42$3.36+$141.1215,162Direct
Jul 23, 2021Common StockPPurchaseAcquired+42$3.35+$140.715,204Direct
Jul 26, 2021Common StockPPurchaseAcquired+42$3.39+$142.3815,246Direct
Jul 27, 2021Common StockPPurchaseAcquired+42$3.39+$142.3815,288Direct
Jul 28, 2021Common StockPPurchaseAcquired+42$3.42+$143.6415,330Direct
Jul 29, 2021Common StockPPurchaseAcquired+42$3.42+$143.6415,372Direct
Jul 30, 2021Common StockPPurchaseAcquired+42$3.31+$139.0215,414Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)